Correlating patient-reported response to hydroxypropyl cellulose ophthalmic insert (LACRISERT®) therapy with clinical outcomes: Tools for predicting response

Current Eye Research

Volumn 35, Issue 10, 2010, Pages 880-887

  McDonald, Marguerite ^a   D'Aversa, Gerard ^a   Perry, Henry D ^a   Wittpenn, John R ^a   Nelinson, Donald S ^b  

^a OPHTHALMIC CONSULTANTS OF LONG ISLAND   (United States)

^b InterQuest Medical   (United States)

Author keywords

Clinical outcomes; Dry eye syndrome; Hydroxypropyl cellulose ophthalmic insert; Ocular Surface Disease Index; Registry

Indexed keywords

HYDROXYPROPYLCELLULOSE;

ADJUVANT THERAPY; ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; DRY EYE; EYE BURNING; EYE DISCOMFORT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OCULAR SURFACE DISEASE INDEX; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHOTOSENSITIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; REGISTER; SELF REPORT; SYMPTOM; TREATMENT OUTCOME; TREATMENT RESPONSE;

CELLULOSE; DRUG DELIVERY SYSTEMS; DRY EYE SYNDROMES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENTS; PHYSICIANS; PROGNOSIS; QUALITY OF LIFE; REGISTRIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77957055800     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2010.495811     Document Type: Article

References (14)

1. The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:75-92.
2. Lemp MA. Advances in understanding and managing dry eye disease. Am J Ophthalmol. 2008;146:350-356.
3. McDonald M, DAversa G, Perry HD, et al. Hydroxypropyl cellulose ophthalmic inserts (LACRISERT) reduce the signs and symptoms of dry eye syndrome and improve patient quality of life. Trans Am Ophthalmol Soc. 2009;107: 214-221.
4. Koffler BH, McDonald M, Nelinson DS; for the LAC-07-01 Study Group. Improved signs, symptoms, and quality of life associated with dry eye syndrome: hydroxypropyl cellulose ophthalmic insert patient registry. Eye Contact Lens. 2010 Mar 26. Epub ahead of print].
5. Smith JA (Epidemiology Editor), et al. The epidemiology of dry eye disease: Report of the Epidemiology Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:93-107.
6. Patel S, Blades K. The dry eye: A practical approach. London, UK: Elsevier Science Limited, 2003.
7. [Lacrisert package insert]. Lawrenceville, NJ: Aton Pharmaceuticals, Inc., 2007.
8. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118:615-621.
9. Levene H. Robust tests for equality of variances. In: I Olkin (Ed.). Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling. Palo Alto, CA: Stanford University Press, 1960; pp. 278-292.
10. Lindman HR. Analysis of variance in complex experimental designs. San Francisco: WH Freeman & Co., 1974.
11. Miljanovic B, Dana R, Sullivan DA, et al. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143:409-415.
12. Hemphill JF. Interpreting magnitudes of correlation coefficients. Am Psychol. 2003;58:78-80.
13. Cohen J. A power primer. Psychol Bull. 1992;112:155-159.
14. Byrne MK, Deane FP, Caputi P. Mental health clinicians beliefs about medicines, attitudes, and expectations of improved medication adherence in patients ePub ahead of print September 30, 2008]. Eval Health Prof. 2008;31:390-403.